StocksFundsScreenerSectorsWatchlists
NAOV

NAOV - NanoVibronix Inc Stock Price, Fair Value and News

0.76USD-0.06 (-7.32%)Market Closed

Market Summary

NAOV
USD0.76-0.06
Market Closed
-7.32%

NAOV Stock Price

View Fullscreen

NAOV RSI Chart

NAOV Valuation

Market Cap

2.3M

Price/Earnings (Trailing)

-0.62

Price/Sales (Trailing)

1

EV/EBITDA

0.41

Price/Free Cashflow

-0.63

NAOV Price/Sales (Trailing)

NAOV Profitability

Operating Margin

67.32%

EBT Margin

-161.28%

Return on Equity

-93.05%

Return on Assets

-55.6%

Free Cashflow Yield

-157.81%

NAOV Fundamentals

NAOV Revenue

Revenue (TTM)

2.3M

Rev. Growth (Yr)

421.95%

Rev. Growth (Qtr)

156.99%

NAOV Earnings

Earnings (TTM)

-3.7M

Earnings Growth (Yr)

60.51%

Earnings Growth (Qtr)

-11.83%

Breaking Down NAOV Revenue

Last 7 days

-10.9%

Last 30 days

-9.9%

Last 90 days

-15.5%

Trailing 12 Months

-74.4%

How does NAOV drawdown profile look like?

NAOV Financial Health

Current Ratio

2.64

NAOV Investor Care

Shares Dilution (1Y)

67.50%

Diluted EPS (TTM)

-2.88

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.1M1.5M1.9M2.3M
20221.9M2.0M1.6M752.0K
2021612.0K661.0K1.0M1.7M
2020565.0K571.0K620.0K623.0K
2019319.5K450.5K497.5K530.0K
2018264.0K344.0K333.0K317.5K
2017224.0K214.0K218.0K239.0K
2016175.0K198.0K219.0K229.0K
2015189.0K175.0K161.0K147.0K
2014000203.0K

Tracking the Latest Insider Buys and Sells of NanoVibronix Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 05, 2023
mika thomas
bought
12,500
0.25
50,000
-
Jun 15, 2022
fashek christopher m
bought
23,828
0.5957
40,000
-
Jun 14, 2022
brown stephen russell
bought
2,295
0.5739
4,000
chief financial officer
Jun 01, 2022
cassirer aurora
bought
1,380
0.69
2,000
-
Sep 29, 2020
fashek christopher m
bought
7,887
0.7887
10,000
-
Nov 20, 2019
fashek christopher m
bought
50,000
2.00
25,000
-

1–6 of 6

Which funds bought or sold NAOV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 11, 2024
VANGUARD GROUP INC
added
6.26
-21,257
34,723
-%
Feb 26, 2024
Virtu Financial LLC
sold off
-100
-27,000
-
-%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
unchanged
-
-1.00
1.00
-%
Feb 13, 2024
RENAISSANCE TECHNOLOGIES LLC
new
-
47,000
47,000
-%
Feb 13, 2024
MORGAN STANLEY
unchanged
-
-8.00
12.00
-%
Feb 13, 2024
ARMISTICE CAPITAL, LLC
sold off
-100
-57,175
-
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
added
68.38
-105
6,051
-%
Feb 13, 2024
BlackRock Inc.
unchanged
-
-61.00
85.00
-%
Feb 13, 2024
GEODE CAPITAL MANAGEMENT, LLC
unchanged
-
-11,858
16,630
-%
Feb 09, 2024
WELLS FARGO & COMPANY/MN
added
8.33
-9.00
15.00
-%

1–10 of 17

Are Funds Buying or Selling NAOV?

Are funds buying NAOV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NAOV
No. of Funds

Unveiling NanoVibronix Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
armistice capital, llc
9.99%
227,009
SC 13G
Feb 16, 2021
kennedy capital management, inc.
0.0%
0
SC 13G/A
Feb 12, 2021
packer paul
8.0%
1,671,426
SC 13G/A
Feb 10, 2021
hirschman orin
3.9%
771,462
SC 13G/A
Jan 19, 2021
alpha capital anstalt
3.34%
645,723
SC 13G/A
Sep 04, 2020
armistice capital, llc
0%
0
SC 13G
Aug 27, 2020
alpha capital anstalt
9.97%
930,000
SC 13G
Feb 14, 2020
kennedy capital management, inc.
7.2%
320,682
SC 13G/A
Feb 14, 2020
hirschman orin
8.79%
352,953
SC 13G/A
Feb 14, 2020
packer paul
9.0%
378,514
SC 13G/A

Recent SEC filings of NanoVibronix Inc

View All Filings
Date Filed Form Type Document
Apr 09, 2024
8-K
Current Report
Apr 09, 2024
10-K/A
Annual Report
Apr 08, 2024
10-K
Annual Report
Apr 01, 2024
NT 10-K
NT 10-K
Mar 28, 2024
8-K
Current Report
Feb 26, 2024
4
Insider Trading
Feb 26, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading

Peers (Alternatives to NanoVibronix Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
192.9B
40.1B
-7.05% 8.96%
33.71
4.81
-8.12% -17.45%
69.7B
19.5B
2.46% -3.05%
55.47
3.57
4.02% -22.04%
24.6B
3.9B
5.71% -0.10%
55.35
6.38
3.42% 23.09%
21.3B
14.8B
-2.15% 1.57%
8.03
1.44
2.12% 209.17%
MID-CAP
9.7B
2.7B
-1.22% -27.74%
-15.17
3.62
-4.68% 82.43%
9.2B
12.3B
-2.13% -12.78%
22.2
0.75
-2.44% -22.68%
9.2B
3.5B
-2.01% 17.72%
32.35
2.64
4.97% 18.89%
6.7B
4.0B
-2.67% -17.42%
-49.97
1.69
1.10% 85.84%
3.5B
366.4M
0.16% 20.41%
-568.95
9.42
33.86% 89.83%
2.3B
6.6B
-2.32% 0.38%
11.88
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-4.15% -14.40%
-1.94
0.41
7.73% -1066.14%
384.0M
166.7M
2.16% -8.23%
-4.65
2.3
6.67% -456.34%
274.4M
324.0M
22.93% -25.61%
-1.43
0.85
-3.19% -337.41%
50.9M
52.3M
-23.44% -54.63%
-2.72
0.97
17.61% 19.28%
4.3M
3.7M
-1.78% 336.84%
-0.36
1.16
5.77% 8.23%

NanoVibronix Inc News

Latest updates
Defense World06 Apr 202409:20 am
TradingPedia31 Mar 202402:15 pm
CNN26 Mar 202401:35 pm
InvestorPlace7 months ago
Value the Markets16 months ago
StockNews.com2 years ago

NanoVibronix Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue157.0%1,177,000458,000294,000354,000225,50097,000485,000272,000775,000499,000318,000103,00090,000150,000269,000114,00087,000101,000263,00079,00054,500
Cost Of Revenue303.7%440,000109,00078,000119,000198,00017,000204,000166,000518,000271,000110,00026,00064,00051,000231,00063,000113,00054,00056,00026,00035,000
Gross Profit111.2%737,000349,000216,000235,000-300,00080,000281,000106,000257,000228,000208,00077,00026,00099,00038,00051,000-26,00047,000207,00053,00019,500
Operating Expenses41.2%1,439,0001,019,0001,225,0001,290,0001,408,0001,004,0001,549,0001,218,0002,767,0001,096,0001,199,0001,391,0001,566,000903,0001,506,000958,0001,213,000840,0001,103,0002,276,0001,382,000
  S&GA Expenses22.6%233,000190,000227,000214,000205,000217,000333,000210,000249,000245,000296,000311,000270,000289,000180,000254,000276,000228,000271,000321,000341,000
  R&D Expenses87.9%62,00033,00035,00055,000107,00049,00061,00066,000115,00050,00064,00064,00040,00068,00016,00047,000133,00079,000150,000152,000206,000
EBITDA Margin33.3%-1.61-2.42-3.17-4.44-6.74-3.51-5.61-5.54-8.31-12.42-10.41-13.29---------
Interest Expenses-391.4%-102,00035,00033,00034,000--------24,000123,000--5,0005,000-2,0007,000-
Income Taxes266.7%11,0003,00013,0002,000-3,00015,00016,0007,000-55,00070,000-4,00021,00022,000-20,0004,0009,000-37,0002,0006,00012,000-127,000
Earnings Before Taxes-10.8%-802,000-724,000-1,061,000-1,095,000-2,062,000-940,000-1,286,000-1,125,000-2,529,000-6,605,000-220,000-4,896,000-984,000-942,000-1,473,000-912,000-1,230,000-813,000-1,101,000-2,667,000-4,281,000
EBT Margin38.0%-1.61-2.60-3.40-4.74-7.20-3.61-5.68-5.62-8.41-12.58-10.65-13.55---------
Net Income-11.8%-813,000-727,000-1,074,000-1,097,000-2,059,000-955,000-1,302,000-1,132,000-2,474,000-6,675,000-216,000-4,917,000-1,006,000-922,000-1,477,000-921,000-1,193,000-815,000-1,107,000-2,679,000-1,197,000
Net Income Margin42.9%-1.63-2.85-3.57-4.77-7.24-3.60-5.70-5.63-8.43-12.69-10.68-13.60---------
Free Cashflow28.0%-491,000-682,000-1,229,000-1,201,000-1,330,000-1,966,000-1,999,000-1,741,000-863,000-635,000-1,916,000-956,000---------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-9.3%6,6747,3613,8314,8115,8795,2106,5427,6638,6229,6666,8328,6038,2294,1021,0091,1212,0363,0703,1078171,580
  Current Assets-9.5%6,4877,1683,6144,5655,6094,9896,3097,3908,3429,4256,5848,3577,9703,9047659141,8382,8472,8894521,230
    Cash Equivalents-100.0%-3,7872531,5122,7131,9723,9445,9907,7378,5995,6727,9537,1423,181-93.001,3382,2582,371184896
  Inventory-14.1%2,7323,1793,1142,2132,1751,553928355175201205173145109148111121104102141144
  Net PPE0%7.007.007.007.007.008.007.005.005.006.005.005.004.002.003.003.004.005.006.006.008.00
Liabilities0.6%2,6862,6712,6662,6082,6462,0562,4082,4022,3099552,6684,2565,8358351,7936236888401,1721,2861,117
  Current Liabilities2.6%2,4542,3922,3702,2892,3161,7152,0532,0071,9032663918762,9023641,250352409522865702640
Shareholder's Equity-15.0%3,9884,6901,1652,2003,2333,1544,1345,2616,3138,7114,1644,3472,3943,267-4981,3472,2301,935-463
  Retained Earnings-1.2%-66,096-65,283-64,556-63,482-62,385-60,326-59,371-58,069-56,937-54,463-47,788-47,572-42,655-41,650-40,728-39,251-38,330-37,137-36,322-35,215-32,536
  Additional Paid-In Capital0.2%70,14970,02565,77465,70865,63463,44963,46863,24863,18963,08651,86751,83244,95944,90139,93539,74039,66939,35838,24934,74032,993
Shares Outstanding11.1%2,0461,8421,6621,6621,6411,4001,4001,4001,4001,3051,2391,2091,062--------
Float---4,831---17,539---9,447,579---9,447,579------
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations28.0%-491-682-1,229-1,200-1,331-1,964-1,999-1,741-863-634-1,916-954-1,318-695-483-895-1,032-1,113-792-937-881
  Share Based Compensation244.4%12436.0066.0067.0067.00-19.0022086.00268-94.0099.0010950.0018372.0071.001991101111,335169
Cashflow From Investing-----1.001.00-2.00----1.00--2.00---------
Cashflow From Financing-100.0%-4,215-7.00-----3,562-3881,4065,2574,023--1121,0002,97922550.00

NAOV Income Statement

2023-12-31
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]  
Revenues$ 2,283,000$ 752,000
Cost of revenues746,000585,000
Gross profit1,537,000167,000
Operating expenses:  
Research and development185,000283,000
Selling and marketing864,000965,000
General and administrative3,924,0003,931,000
Total operating expenses4,973,0005,179,000
Loss from operations(3,436,000)(5,012,000)
Interest expense(135,000)(347,000)
Financial expense, net(111,000)(54,000)
Loss before taxes(3,682,000)(5,413,000)
Income tax expense(29,000)(35,000)
Net loss$ (3,711,000)$ (5,448,000)
Basic net loss available for holders of common stock$ (2.12)$ (3.84)
Diluted net loss available for holders of common stock$ (2.12)$ (3.84)
Weighted average common stock outstanding, basic1,750,1091,419,670
Weighted average common stock outstanding, diluted1,750,1091,419,670
Comprehensive loss:  
Net loss available to common stockholders$ (3,711,000)$ (5,448,000)
Change in foreign currency translation adjustments(49,000)(78,000)
Comprehensive loss available to common stockholders$ (3,760,000)$ (5,526,000)

NAOV Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash$ 3,283,000$ 2,713,000
Trade receivables318,0009,000
Prepaid expenses and other accounts receivable154,000712,000
Inventory2,732,0002,175,000
Total current assets6,487,0005,609,000
Noncurrent assets:  
Fixed assets, net7,0007,000
Other assets1,0003,000
Severance pay fund174,000179,000
Operating lease right-of-use assets, net5,00081,000
Total non-current assets187,000270,000
Total assets6,674,0005,879,000
Current liabilities:  
Trade payables138,00066,000
Other accounts payable and accrued expenses2,265,0002,148,000
Deferred revenue46,00021,000
Operating lease liabilities, current5,00081,000
Total current liabilities2,454,0002,316,000
Non-current liabilities:  
Accrued severance pay217,000223,000
Deferred revenue – long term15,000107,000
Total liabilities2,686,0002,646,000
Commitments and contingencies
Stockholders’ equity:  
Common stock of $0.001 par value - Authorized: 40,000,000 shares at December 31, 2023 and December 31, 2022, respectively; Issued and outstanding: 2,046,307 and 1,641,146 shares at December 31, 2023 and December 31, 2022, respectively2,0002,000
Additional paid in capital70,149,00065,634,000
Accumulated other comprehensive income(67,000)(18,000)
Accumulated deficit(66,096,000)(62,385,000)
Total stockholders’ equity3,988,0003,233,000
Total liabilities and stockholders’ equity6,674,0005,879,000
Series C Preferred Stock [Member]  
Stockholders’ equity:  
Preferred Stock Value
Series D Preferred Stock [Member]  
Stockholders’ equity:  
Preferred Stock Value
Series E Preferred Stock [Member]  
Stockholders’ equity:  
Preferred Stock Value
Series F Preferred Stock [Member]  
Stockholders’ equity:  
Preferred Stock Value
NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.
 CEO
 WEBSITEnanovibronix.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES9

NanoVibronix Inc Frequently Asked Questions


What is the ticker symbol for NanoVibronix Inc? What does NAOV stand for in stocks?

NAOV is the stock ticker symbol of NanoVibronix Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NanoVibronix Inc (NAOV)?

As of Tue Apr 09 2024, market cap of NanoVibronix Inc is 2.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NAOV stock?

You can check NAOV's fair value in chart for subscribers.

What is the fair value of NAOV stock?

You can check NAOV's fair value in chart for subscribers. The fair value of NanoVibronix Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of NanoVibronix Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NAOV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is NanoVibronix Inc a good stock to buy?

The fair value guage provides a quick view whether NAOV is over valued or under valued. Whether NanoVibronix Inc is cheap or expensive depends on the assumptions which impact NanoVibronix Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NAOV.

What is NanoVibronix Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 09 2024, NAOV's PE ratio (Price to Earnings) is -0.62 and Price to Sales (PS) ratio is 1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NAOV PE ratio will change depending on the future growth rate expectations of investors.